Weber Barbara
SEC insider (Form 3/4/5 filer). CIK 0001800670. Director at Parabilis Medicines, Inc. (PBLS) and 2 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in CAMBRIDGE, MA.
Companies Weber Barbara has filed insider reports for
- Parabilis Medicines, Inc. (PBLS): Director
- Tango Therapeutics, Inc. (TNGX): Director, Officer, Director, Executive Chair
- Revolution Medicines, Inc. (RVMD): Director
Weber Barbara
CIK: 0001800670
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 9, 2026PBLS
Parabilis Medicines, Inc.
AwardDirectStock Option (Right to Buy)
20.2K shares- - Feb 3, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect30.2K shares at avg. $12.26$370K - Feb 3, 2026TNGX
Tango Therapeutics, Inc.
SaleDirect333 shares at avg. $12.90$4K - Feb 2, 2026TNGX
Tango Therapeutics, Inc.
AwardDirect37.5K shares- - Feb 5, 2025TNGX
Tango Therapeutics, Inc.
SaleDirect9K shares at avg. $3.16$28K - Feb 4, 2025TNGX
Tango Therapeutics, Inc.
SaleDirect9.8K shares at avg. $2.99$29K - Feb 3, 2025TNGX
Tango Therapeutics, Inc.
AwardDirect105.9K shares- - Oct 8, 2024RVMD
Revolution Medicines, Inc.
SaleDirect5.2K shares at avg. $48.02$250K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  PBLS Parabilis Medicines, Inc. | Award Stock Option (Right to Buy) | 20,215 | - | - | Direct |
| Feb 3, 2026 |  TNGX Tango Therapeutics, Inc. | Sale | 30,186 | $12.26 | $369,999 | Direct |
| Feb 3, 2026 | TNGX Tango Therapeutics, Inc. | Sale | 333 | $12.90 | $4,295 | Direct |
| Feb 2, 2026 | TNGX Tango Therapeutics, Inc. | Award | 37,522 | - | $0 | Direct |
| Feb 5, 2025 | TNGX Tango Therapeutics, Inc. | Sale | 9,013 | $3.16 | $28,494 | Direct |
| Feb 4, 2025 | TNGX Tango Therapeutics, Inc. | Sale | 9,778 | $2.99 | $29,217 | Direct |
| Feb 3, 2025 | TNGX Tango Therapeutics, Inc. | Award | 105,875 | - | - | Direct |
| Oct 8, 2024 |  RVMD Revolution Medicines, Inc. | Sale | 5,200 | $48.02 | $249,716 | Direct |
1-8 of 8 transactions